![(3S,6R,7S,12Z,15S,16E)-3,7-Bis-{[tert-butyl(dimethyl)silyl]oxy}-15-hydroxy-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-](https://media.scbt.com/product/3s-6r-7s-12z-15s-16e-3-7-bis-tert-butyl-dimethyl-silyloxy-15-hydroxy-4-4-6-8-12-16-hexamethyl-17-2-methyl-1-3-thiazol-4-yl-5-oxoheptadeca-12-16-dienoic-acid-193146-26-8-structure_08_73_b_87373.jpg)
![Molecular structure of (3S,6R,7S,12Z,15S,16E)-3,7-Bis-{[tert-butyl(dimethyl)silyl]oxy}-15-hydroxy-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxoheptadeca-12,16-dienoic Acid, CAS Number: 193146-26-8 (3S,6R,7S,12Z,15S,16E)-3,7-Bis-{[tert-butyl(dimethyl)silyl]oxy}-15-hydroxy-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-](https://media.scbt.com/product/3s-6r-7s-12z-15s-16e-3-7-bis-tert-butyl-dimethyl-silyloxy-15-hydroxy-4-4-6-8-12-16-hexamethyl-17-2-methyl-1-3-thiazol-4-yl-5-oxoheptadeca-12-16-dienoic-acid-193146-26-8-structure_08_73_t_87373.jpg)
QUICK LINKS
Intermediary obtained in the synthesis of members of the Epothilone family, polyketide natural products that inhibit cancer cells via a mechanism similar to Paclitaxel. Also found to be effective against Paclitaxel-resistant tumors. Currently in Phase I of clinical testing.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
(3S,6R,7S,12Z,15S,16E)-3,7-Bis-{[tert-butyl(dimethyl)silyl]oxy}-15-hydroxy-4,4,6,8,12,16-hexamethyl-17-(2-methyl-1,3-thiazol-4-yl)-5-oxoheptadeca-12,16-dienoic Acid, 100 µg | sc-206740 | 100 µg | $230.00 |